Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports modulation of neurotransmitter receptors, making it valuable in creating potential antipsychotic, antidepressant, and analgesic drugs. The presence of the trifluoromethyl group enhances metabolic stability and binding affinity, which improves drug efficacy. It is also employed in research settings for structure-activity relationship (SAR) studies to optimize lead compounds in medicinal chemistry.